In addition, our result revealed that B-cell lymphoma patients with the presence of co-mutated TP53 and Hippo pathways had the worst prognosis, compared to patients with mutations in either pathway or without any mutation in both pathways. The gene discussed is TP53; the disease is B-cell non-Hodgkin lymphoma.